Abstract
Among the movement disorders progressive supranuclear palsy (PSP) is a degenerative neurological disease characterized by a loss of voluntary control of vertical gaze, dysarthria, diffuse body rigidity with dystonic extension of the neck and dementia (Steele, 1975).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baron, J.C., Samson, Y., Crouzel, C. et al. 1985b. Pharmacologic studies in man with PET: an investigation using l-labeled ketanserin, a 5-HT2 receptor antagonist. In “Cerebral Blood Flow and Metabolism Measurement”. (Eds. A. Hartmann, S. Hoyer). (Springer, Berlin, Heidelberg, New York), pp. 473–480.
Baron, J.C., Comar, D., Zarifian, E. et al. 1985a. Dopaminergic receptor sites in human brain: positron emission tomography. Neurology, 35, 1624.
Bokobza, B., Ruberg, M., Scatton, B. et al. 1984. 3H-spiperone binding, dopamine and HVA concentrations in Parkinson’s disease and supranuclear palsy. Eur. J. Pharmacol., 99, 167–175.
Crawley, J.C.W., Smith, T., Yeall, N. et al. 1983. Dopamine receptors displayed in human living brain with 77Br-p-bromospiperone. Lancet, II, 975.
Farde, L., Ehrin, E., Eriksson, L. et al. 1985. l-labeled dopamine-2-receptor antagonists as tools for quantitative studies or dopamine receptors in the human brain. In “Brain 85”, 16–20 June 1985, Ronneby, Sweden, pp. 205.
Friedman, A.M., Dejesus, O.T., Revenaugh, B.A. et al. 1984. Measurements in vivo of parameters of the dopamine system. Ann. Neurol., 15, (Suppl.), 566–576.
Frost, J.J., Wagner, H.N., Dannals, R.F. et al. 1985. Imaging opiate receptors in the human brain by positron tomography. J. Comput. Assist. Tomogr., 9, 231–236.
Huang, C.C., Friedman, A.M., So, R. et al. 1980. Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug. J. Pharm. Sci., 69, 984–986.
Kulmala, H.K., Huang, C.C., Dinerstein, R.J. et al. 1981. Specific in vivo binding of 77-Br-p-bromospiroperidol in rat brain: a potential tool for gamma ray imaging. Life Sci., 28, 1911–1916.
Laduron, P.M., Janssen, P.F.M., Leysen, J.E. 1978. Spiperone, a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement by neuroleptic drugs. Biochem. Pharmacol., 27, 371–321.
Leenders, K.L., Herold, S., Brooks, D.J. et al. 1984. Pre-synaptic and post-synaptic dopaminergic systems in human brain. Lancet, II, 110–111.
Mazière, B., Loc’h, C., Hantraye, P. et al. 1984. 76-Br-bromospiperidol: a new tool for quantitative in vivo imaging of neuroleptic receptors. Life Sci., 35, 1349–1356.
Mazière, B., Loc’h, C., Baron, J.C. et al.1985. In vivo quantitative imaging of dopamine receptors in human brain using positron tomography and 76Br-bromospiperone. Eur. J. Pharmacol., 114, 267–272.
Mazziotta, J.C., Phelps, M.E., Miller, J. et al. 1981. Tomographic mapping of human cerebral metabolism: normal unstimulated state. Neurology, 31, 503–516.
Mintun, M.A., Raichle, M.E., Kilbourn, M.R. et al. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol., 15, 217–227.
Owen, F., Poulter, M., Marshall, R.D. et al. 1983. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors. Life Sci., 3, 765–768.
Phelps, M.E., Mazziotta, J.U. 1985. Positron emission tomography: human brain function and biochemistry. Science, 228, 799–809.
Ruberg, M., Bokobza, B., Javoy-Agid, F. et al. 1984. 3H-spiperone binding in the nigrostriatal system in human brain. Eur. J. Pharmacol., 99, 159–165.
Ruberg, M., Javoy-Agid, F., Hirsch, E. et al. 1985. Aminergic, cholinergic, and gabaergic systems in the brain of patients with progressive supranuclear palsy. Ann. Neurol., 18, 523–529.
Samson, Y., Hantraye, P., Baron, J.C. et al. 1985. Kinetics and displacement of 11C-R0 15–1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. Eur. J. Pharmacol., 110, 247–251.
Soussaline, F., Campagnolo, R., Verrey, B. et al. 1984. Physical characterization of a time-of-flight positron emission tomography system for wholebody quantitative studies. J. Nucl. Med., 25, P46.
Steele, J.C. 1975. Progressive supranuclear palsy. In “Handbook of Neurology”, Vol. 22. (Eds. Vinken, Bruyn). (Elsevier Pubi. Comp.). pp. 217–229.
Stoof, J.C. 1983. Dopamine receptors in the neostriatum: Biochemical and physiological studies. In “Dopamine Receptors”. (Eds. C. Kaiser, J.W. Kebabian). (A.C.S. Symposium Series, Vol. 224). pp. 117–145.
Syrota, A., Paillotin, G., Davy, J.M. et al. 1984. Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. Life Sci., 35, 837–845.
Wagner, H.N., Burns, H.D., Dannais, R.F. et al. 1983. Imaging dopamine receptors in the human brain by positron tomography. Science, 221, 1264–1266.
Wong, D.F., Wagner, H.N., Dannais, R.F. et al. 1984. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science, 1393–1396.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 ECSC, EEC, EAEC, Brussels-Luxembourg
About this chapter
Cite this chapter
Mazière, B., Baron, J.C., Loc’h, C., Cambon, H., Agid, Y. (1987). Progressive Supranuclear Palsy Studied by Pet. In: Heiss, WD., Pawlik, G., Herholz, K., Wienhard, K. (eds) Clinical efficacy of positron emission tomography. Developments in Nuclear Medicine, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3345-3_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-3345-3_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8002-6
Online ISBN: 978-94-009-3345-3
eBook Packages: Springer Book Archive